Partnerships with academia play an important role in enhancing development and implementation processes of in-vitro diagnostic technologies. At M4IVD, we are proud to welcome Dr. Philip D. Howes, as individual member. Philip, is a Senior Researcher in the Institute for Chemical and Bioengineering at ETH Zürich. Dr. Philip Howes, why do you think now is […]
We are delighted to welcome Mulier Health GmbH to our growing list of M4IVD members. Mulier Health GmbH`s mission is to give every woman the option to track her health. Therefore, they develop personalized innovative health-tracking platforms based on latest scientific knowledge and technologies. Their platforms combine innovative in-vitro diagnostic test devices for home use with smart […]
M4IVD is growing stronger with every new member. Joining us in May, swiss startup Bioinitials brings a variety of expertise and knowledge to our expanding community. Based on biochemical sensors, BioInitials is creating a device to evaluate saliva biomarkers for monitoring health. Their goal is to increase the degree of oral health among the general […]
Swiss TPH in Basel submitted one of eleven projects that will receive funding from the Botnar Research Centre for Child Health (BRCCH) and Fondation Botnar. This Fast Track Call for Acute Global Health Challenges (FTC) is a new initiative that supports research in three areas to respond to the global COVID-19 crisis. Swiss TPH (Tropical […]
Impressive how much expertise is in this group that met online, to discuss ways to combat COVID19! Agathe Koller, Amar Rida, Anne Timm, Christian Bosshard, Frank Dieterle, Christof Kloepper, Christoph Joder, Daniel Gygax, Daniel Paris, Frank Kumli, Franziska Stemmler, Hans-Florian Zeilhofer, Nila-Pia Rähle, Karina Candrian, Patrick Scotton, Peter Spies, Philip Howes, Soeren Fricke, Ulrich Stärker, […]
Soeren Fricke from CSEM and Syed Rafiq Hussain from HEMEX AG gave an insightful presentation on M4IVD Association at the CSEM Business Day 2019. M4IVD is a research alliance that supports life science startups by developing point-of-care in-vitro diagnostics and filling the gap between R&D and manufacturing for Swiss biotech startups.